Despite gene rearrangements, such as the TMPRSS2-ERG genes fusion [76], recurrent mutations in the speckle-type POZ (SPOP) gene occur in up to 15% of prostate cancers making SPOP the most commonly affected gene by nonsynonymous point mutations in prostate cancer [52]. This evidence concerns the gene ERG and Familial prostate cancer.